The US Food and Drug
Administration has allowed
marketing of the Cerena
Transcranial Magnetic Stimulator,
which is the first device to relieve
pain caused by migraine headaches
that are preceded by an aura.
The Cerena TMS is a prescription
device, with users holding it against
the back of the head and pressing
a button to release a pulse of
magnetic energy to stimulate the
occipital cortex in the brain.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Dec 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Dec 13
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
THE Pharmaceutical Society of Australia (PSA) has unveiled a comprehensive membership package designed to provide robust support for credentialed pharmacists throughout their professional journey.
MEDICAL research produces better outcomes when people with lived experience are involved in the process, according to Breast Cancer Network Australia (BCNA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.